Concealed death of child in China gene-editing trial sparks probe and scientific integrity concerns
The unauthorized trial of a customized base-editing treatment on a six-year-old girl exposes severe compliance gaps…
China hits brain-computer interface milestone, but success masks steep commercial and financial hurdles
Despite a landmark implant, China’s brain-computer interface startups face grueling rehabilitation realities and prohibitive out-of-pocket costs…
China adds 67 unicorns in first half as artificial intelligence and robotics drive startup rebound
A surge in AI and robotics startups has lifted China’s unicorn creation to its strongest half-year…
Biokin’s new cancer drug secures historic approval in China, but Western regulatory hurdles loom
Backed by an $8.4 billion international licensing deal with Bristol Myers Squibb, Biokin’s groundbreaking dual-target therapy…
Early Shanghai trial data points to promise for therapeutic mRNA cancer vaccines
By Da Cheung The American Society of Clinical Oncology (ASCO) annual meeting, which concluded on June…
Beyond Neuralink: China’s BCI industry shatters funding records as government backs brain-computer interfaces
By Da Cheung Chinese companies developing brain-computer interface (BCI) systems are witnessing a surge in fundraising this…
Tiny tech, huge impact: how micro six-axis sensors are giving robots a human touch
By Da Cheung For years, modern imaging and robotics have been giving machines an ever-clearer view…
From Everest to Walmart: exoskeleton startup Hypershell secures over $50 million in fresh funding
By Da Cheung Exoskeletons — once clunky medical devices restricted to rehabilitation centers or science fiction…
Chinese innovative drug makers step onto the global stage through licensing and foreign co-co deals
By Da Cheung In 2025, China’s innovative pharmaceutical companies quietly crossed a historic threshold, overtaking the…
How tech giant Huawei is helping China’s hospitals develop unified AI operating systems
By Lin Jianlan Inside the gleaming atrium of Nanfang Hospital in Guangzhou, an experiment is underway…
Latest
- The $25 Billion IPO: how Huawei spinoff Honor is reinventing itself as an AI giant
- Robot maker Unitree’s blockbuster IPO tests global AI hardware hype
- As Japan’s energy storage market booms, Chinese equipment suppliers are feeling the chill
- WuWen AI: the Chinese AI startup aiming to solve the data bottleneck facing embodied intelligence
- As AI-generated micro-dramas take off in China, their stars are turning into social media influencers
